Bacterial co-abundance networks decreases in complexity with lower host genetic variation. by Michael Ørsted (5926028)

Plerixafor decreased the frequency of LAG-3+ CD4+ T cells in septic mice. by Kimberly M. Ramonell (4678906)

“…N = 3–5 mice/group. Representative of 3 independent experiments with a total of 12 mice/group.…”

RelA–TA2 docks itself onto a series of interlinked hydrophobic grooves of TAZ1 through a number of hydrophobic residues, which serve as anchor points. by Sulakshana P. Mukherjee (453389)

“…The Leu449Ala and Leu465Ala mutants in RelA–TA2 lead to diminished association constants accompanied with decreased negative enthalpy change. …”

Chronic hyperoxia decreases relaxant response to acetylcholine in intrapulmonary arteries of newborn rats. by Eric Dumas de la Roque (3779935)

“…<p>(A) Arterial relaxant response to acetylcholine was significantly decreased by hyperoxia (<i>n</i> = 8 vessels from 3 animals) compared with normoxia (<i>n</i> = 15 vessels from 5 animals). …”

Decreased immunofluorescence signals for the CAMs at the synapses in cultured afadin-deficient hippocampal neurons. by Daisaku Toyoshima (528270)

Scatter plot according to the type of ODD. by Kyoung Min Lee (677987)

Cytotoxic effect of Eltrombopag on AML cells is dependent on dose and serum concentration. by Anna Kalota (7415)

“…C) Summary of the E’s effect on human primary AML cells n = 9 compared to peripheral blood mononuclear cells (PB-MNCs) from normal donors (ND) n = 3 (left panel) and AML cell lines n = 4 (right panel). Graphs demonstrate decrease in a total cell number after exposure to 5 μM E at 2% serum, presented as a percent of control at day 2 for cell lines and day 4 for primary cells.…”

Eltrombopag Does Not Significantly Affect Mitochondria Function and ATP Production. by Anna Kalota (7415)

Demographics and baseline characteristics of the safety population. by Rahsan Erdem (11726357)

Subjects:

iOWH032 inhibits cholera toxin-induced secretion in a mouse closed-loop model. by Rahsan Erdem (11726357)

Subjects:

Grading of stool consistency and diarrhea severity. by Rahsan Erdem (11726357)

Subjects:

Secondary efficacy endpoints for the modified intent-to-treat population. by Rahsan Erdem (11726357)

Subjects:

Study drug–related treatment-emergent adverse events by system organ class and preferred term in the safety population. by Rahsan Erdem (11726357)

Subjects:

Source data for Fig 1. by Rahsan Erdem (11726357)

Subjects:

Diarrheal stool output rate overall and by blood type status in the modified intent-to-treat population. by Rahsan Erdem (11726357)

Subjects:

Source data for S1 and S2 Figs. by Rahsan Erdem (11726357)

Subjects:

Source data for Fig 2. by Rahsan Erdem (11726357)

Subjects:

Consolidated Standards for Reporting of Trials flow diagram. by Rahsan Erdem (11726357)

Subjects:

iOWH032 inhibits cholera toxin-induced fecal output in a cecectomized rat model. by Rahsan Erdem (11726357)

Subjects:

Source data for Fig 3. by Rahsan Erdem (11726357)

Subjects: